Aberdeen Group
NSPR icon

Aberdeen Group’s InspireMD NSPR Stock Holding History

Aberdeen Group’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59M Buy
3,698,364
+525,000
+17% +$557K ﹤0.01% 758
2026
Q1 		$5.17M Hold
3,173,364
– – 0.01% 685
2025
Q4 		$5.65M Buy
3,173,364
+692,247
+28% +$1.44M 0.01% 683
2025
Q3 		$5.98M Buy
+2,481,117
New +$6.02M 0.01% 682

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Aberdeen Group's NSPR Position: Q2 2026 in Review

Aberdeen Group increased its InspireMD (NSPR) stake by 17% in Q2 2026, buying an estimated $557K and bringing the position to 3,698,364 shares worth $2.59M. The position accounts for ﹤0.01% of the portfolio, ranked #758.

Aberdeen Group first reported a position in NSPR in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.98M in Q3 2025. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Aberdeen Group held 3,698,364 shares of InspireMD worth $2.59M as of Q2 2026.
  • Aberdeen Group bought 525,000 InspireMD shares in Q2 2026, an estimated $557K.
  • InspireMD made up ﹤0.01% of Aberdeen Group's portfolio in Q2 2026, its #758 holding.
  • Aberdeen Group first reported a position in InspireMD in Q3 2025 and has held it in 4 quarters since.
  • Aberdeen Group's InspireMD position peaked at $5.98M in Q3 2025.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.